Document Detail


Trochanteric bursitis after total hip arthroplasty: incidence and evaluation of response to treatment.
MedLine Citation:
PMID:  19261433     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We examined the efficacy of corticosteroid injection as treatment for postarthroplasty trochanteric bursitis and the risk factors for failure of nonoperative treatment. There were 32 (4.6%) cases of postsurgical trochanteric bursitis in 689 primary total hip arthroplasties. Of the 25 hips with follow-up, 11 (45%) required multiple injections. Symptoms resolved in 20 (80%) but persisted in 5. We found no statistically significant differences between patients who did and did not develop trochanteric bursitis, or between those who did and did not respond to treatment. There was a trend toward younger age and greater limb-length discrepancy in nonresponders. In conclusion, (1) corticosteroid injection(s) for postoperative trochanteric bursitis is effective; and (2) nonoperative management may be more likely to fail in young patients and those with leg-length discrepancy.
Authors:
Kevin W Farmer; Lynne C Jones; Kirstyn E Brownson; Harpal S Khanuja; Marc W Hungerford
Related Documents :
1101133 - Septic arthritis in children.
8853163 - Therapy with pulsed electromagnetic fields in aseptic loosening of total hip protheses:...
22782273 - Tracheostomy change before day 7 is associated with earlier use of speaking valve and e...
Publication Detail:
Type:  Journal Article     Date:  2009-03-04
Journal Detail:
Title:  The Journal of arthroplasty     Volume:  25     ISSN:  1532-8406     ISO Abbreviation:  J Arthroplasty     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-05-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703515     Medline TA:  J Arthroplasty     Country:  United States    
Other Details:
Languages:  eng     Pagination:  208-12     Citation Subset:  IM    
Copyright Information:
2010 Elsevier Inc. All rights reserved.
Affiliation:
Division of Arthritis Surgery, The Department of Orthopaedic Surgery, The Johns Hopkins University at Good Samaritan Hospital, Baltimore, Maryland 21224-2780, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Cortex Hormones / administration & dosage,  therapeutic use*
Adult
Aged
Aged, 80 and over
Arthralgia / drug therapy,  epidemiology,  etiology
Arthroplasty, Replacement, Hip / adverse effects*
Bursitis / drug therapy*,  epidemiology,  etiology*
Female
Femur*
Hip Joint*
Humans
Incidence
Injections, Intra-Articular
Male
Middle Aged
Osteoarthritis, Hip / surgery
Retrospective Studies
Risk Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Adrenal Cortex Hormones

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  WITHDRAWN: Effects of hormone replacement therapy with oral vitamin C and E on plasma thyroid hormon...
Next Document:  Double-Concave Deformity of the Polyethylene Tibial Post in Posterior Stabilized Total Knee Arthropl...